|
|
|
|
|
Dr. XIAOPING ZHANG
|
|
|
|
|
|
|
|
|
Address 1
|
:
|
|
|
Address 2
|
:
|
|
|
Title
|
:
|
Dr.
|
|
First Name
|
:
|
XIAOPING
|
|
Last Name
|
:
|
ZHANG
|
|
University/Institution
|
:
|
Ican School of Medicine at Mount Sinai
|
|
Phone #
|
:
|
5042367217
|
|
Email ID
|
:
|
zhangxiaopings@gmail.com
|
|
City
|
:
|
new york
|
|
Country
|
:
|
United States
|
|
State
|
:
|
New york
|
|
Zipcode
|
:
|
10029
|
|
|
|
|
|
|
Department
|
:
|
Pharmacology
|
|
Company Name
|
:
|
|
|
Area of Research
|
|
anti-cancer drug development
|
|
Area of Expertise
|
|
anti-caner drug development
|
|
Brief Description of Research Interest :
|
|
PKPD driven drug development for treatment of brain tumor, Characterized PK/PD profile (PK properties, biomarkers in signal transduction pathways, MOA, and efficacy) of compounds by employing “omic”-based approaches in in vitro and in vivo oncological models.
|
|
Representative Publications :
|
Molecular Cancer TherapeuticsFebruary 25, 2014
Preclinical PK/PD evaluation of ON123300 in brain tumor
A multi-scale approach to develop cell type-specific pharmacokinetic/pharmacodynamic models: application to temozolomide in brain tumors
CPT: Pharmacometrics & Systems Pharmacology2014
Cell-type specific temozolomide PK/PD modeling
Integrated Pharmacokinetic-Driven Approach to Screen Candidate Anticancer Drugs for Brain Tumor Chemotherapy
AAPS J2013
|
|
Resume
|
:
|
Download
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|